Human Cell

, Volume 32, Issue 1, pp 51–63 | Cite as

Human amniotic fluid stem cells have a unique potential to accelerate cutaneous wound healing with reduced fibrotic scarring like a fetus

  • Marie Fukutake
  • Daigo OchiaiEmail author
  • Hirotaka Masuda
  • Yushi Abe
  • Yu Sato
  • Toshimitsu Otani
  • Shigeki Sakai
  • Noriko Aramaki-Hattori
  • Masayuki Shimoda
  • Tadashi Matsumoto
  • Kei Miyakoshi
  • Yae Kanai
  • Kazuo Kishi
  • Mamoru Tanaka
Research Article


Adult wound healing can result in fibrotic scarring (FS) characterized by excess expression of myofibroblasts and increased type I/type III collagen expression. In contrast, fetal wound healing results in complete regeneration without FS, and the mechanism remains unclear. Amniotic fluid cells could contribute to scar-free wound healing, but the effects of human amniotic fluid cells are not well characterized. Here, we determined the effect of human amniotic fluid stem cells (hAFS) on FS during wound healing. Human amniotic fluid was obtained by amniocentesis at 15–17 weeks of gestation. CD117-positive cells were isolated and defined as hAFS. hAFS (1 × 106) suspended in PBS or cell-free PBS were injected around wounds created in the dorsal region of BALB/c mice. Wound size was macroscopically measured, and re-epithelialization in the epidermis, granulation tissue area in the dermis and collagen contents in the regenerated wound were histologically analyzed. The ability of hAFS to engraft in the wound was assessed by tracking hAFS labeled with PKH-26. hAFS fulfilled the minimal criteria for mesenchymal stem cells. hAFS injection into the wound accelerated wound closure via enhancement of re-epithelialization with less FS. The process was characterized by lower numbers of myofibroblasts and higher expression of type III collagen. Finally, transplanted hAFS were clearly observed in the dermis until day 7 implying that hAFS worked in a paracrine manner. hAFS can function in a paracrine manner to accelerate cutaneous wound healing, producing less FS, a process resembling fetal wound healing.


Human amniotic fluid stem cell Wound healing Epithelialization Fibrosis Scar formation 



This work was supported by JSPS Grant-in-Aid for Scientific Research (C) Grant number JP15K09724 (, JSPS Grant-in-Aid for Scientific Research (B) Grant number 17H04236 (, JSPS Grant-in-Aid for Challenging Exploratory Research Grant number JP16K15536 (, JAOG Ogyaa Donation Foundation (, Japan Spina Bifida and Hydrocephalus Research Foundation (, Keio Gijuku Academic Development Funds research funding (individual research) (, and Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics (

Author contributions

MF, DO, HM, SS, NA, MS, YK, KK, and MT conceived and designed the experiments. MF, DO, YA, and TO performed the experiments. MF, DO, HM, YA, TO, SS, NA, MS, TM, KM, YK, KK, and MT analyzed the data. SS and MS contributed reagents/materials/analytic tools. MF, DO, HM, and MT wrote the paper.

Compliance with ethical standards

Conflict of interest

The authors have no conflicts of interest to declare.

Supplementary material

13577_2018_222_MOESM1_ESM.pptx (5.9 mb)
Supplementary material 1 (PPTX 6088 KB)
13577_2018_222_MOESM2_ESM.pptx (54 kb)
Supplementary material 2 (PPTX 53 KB)


  1. 1.
    Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med. 1999;341(10):738–746. Scholar
  2. 2.
    Kishi K, Okabe K, Shimizu R, Kubota Y. Fetal skin possesses the ability to regenerate completely: complete regeneration of skin. Keio J Med. 2012;61(4):101–8. Scholar
  3. 3.
    Hu MS, Maan ZN, Wu JC, Rennert RC, Hong WX, Lai TS, et al. Tissue engineering and regenerative repair in wound healing. Ann Biomed Eng. 2014;42(7):1494–507. Scholar
  4. 4.
    Larson BJ, Longaker MT, Lorenz HP. Scarless fetal wound healing: a basic science review. Plast Reconstr Surg. 2010;126(4):1172–80. Scholar
  5. 5.
    Lo DD, Zimmermann AS, Nauta A, Longaker MT, Lorenz HP. Scarless fetal skin wound healing update. Birth Defects Res C Embryo Today. 2012;96(3):237–47. Scholar
  6. 6.
    Leung A, Crombleholme TM, Keswani SG. Fetal wound healing: implications for minimal scar formation. Curr Opin Pediatr. 2012;24(3):371–8. Scholar
  7. 7.
    Friedman SL, Sheppard D, Duffield JS, Violette S. Therapy for fibrotic diseases: nearing the starting line. Sci Transl Med. 2013;5(167):167 sr1. Scholar
  8. 8.
    Klein JD, Turner CG, Steigman SA, Ahmed A, Zurakowski D, Eriksson E, et al. Amniotic mesenchymal stem cells enhance normal fetal wound healing. Stem Cells Dev. 2011;20(6):969–76. Scholar
  9. 9.
    Jackson WM, Nesti LJ, Tuan RS. Concise review: clinical translation of wound healing therapies based on mesenchymal stem cells. Stem Cells Transl Med. 2012;1(1):44–50. Scholar
  10. 10.
    Li M, Zhao Y, Hao H, Han W, Fu X. Mesenchymal stem cell-based therapy for nonhealing wounds: today and tomorrow. Wound Repair Regen. 2015;23(4):465–82. Scholar
  11. 11.
    Lee DE, Ayoub N, Agrawal DK. Mesenchymal stem cells and cutaneous wound healing: novel methods to increase cell delivery and therapeutic efficacy. Stem Cell Res Ther. 2016;7:37. Scholar
  12. 12.
    De Coppi P, Bartsch G Jr, Siddiqui MM, Xu T, Santos CC, Perin L, et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol. 2007;25(1):100–6. Scholar
  13. 13.
    Loukogeorgakis SP, De Coppi P. Amniotic fluid stem cells: the known, the unknown and potential regenerative medicine applications. Stem Cells. 2016. Scholar
  14. 14.
    Roubelakis MG, Bitsika V, Zagoura D, Trohatou O, Pappa KI, Makridakis M, et al. In vitro and in vivo properties of distinct populations of amniotic fluid mesenchymal progenitor cells. J Cell Mol Med. 2011;15(9):1896–913. Scholar
  15. 15.
    Hattori N, Mochizuki S, Kishi K, Nakajima T, Takaishi H, D’Armiento J, et al. MMP-13 plays a role in keratinocyte migration, angiogenesis, and contraction in mouse skin wound healing. Am J Pathol. 2009;175(2):533–46. Scholar
  16. 16.
    Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315–7. Scholar
  17. 17.
    Perin L, Sedrakyan S, Da Sacco S, De Filippo R. Characterization of human amniotic fluid stem cells and their pluripotential capability. Methods Cell Biol. 2008;86:85–99. Scholar
  18. 18.
    Yan ZJ, Hu YQ, Zhang HT, Zhang P, Xiao ZY, Sun XL, et al. Comparison of the neural differentiation potential of human mesenchymal stem cells from amniotic fluid and adult bone marrow. Cell Mol Neurobiol. 2013;33(4):465–475. Scholar
  19. 19.
    Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature. 2008;453(7193):314–321. Scholar
  20. 20.
    Sun Q, Li F, Li H, Chen RH, Gu YZ, Chen Y, et al. Amniotic fluid stem cells provide considerable advantages in epidermal regeneration: B7H4 creates a moderate inflammation microenvironment to promote wound repair. Sci Rep. 2015;5:11560. Scholar
  21. 21.
    Wu Y, Chen L, Scott PG, Tredget EE. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells. 2007;25(10):2648–2659. Scholar
  22. 22.
    Yoon BS, Moon JH, Jun EK, Kim J, Maeng I, Kim JS, et al. Secretory profiles and wound healing effects of human amniotic fluid-derived mesenchymal stem cells. Stem Cells Dev. 2010;19(6):887–902. Scholar
  23. 23.
    Sakai S, Sato K, Tabata Y, Kishi K. Local release of pioglitazone (a peroxisome proliferator-activated receptor gamma agonist) accelerates proliferation and remodeling phases of wound healing. Wound Repair Regen. 2016;24(1):57–64. Scholar
  24. 24.
    Qi Y, Jiang D, Sindrilaru A, Stegemann A, Schatz S, Treiber N, et al. TSG-6 released from intradermally injected mesenchymal stem cells accelerates wound healing and reduces tissue fibrosis in murine full-thickness skin wounds. J Invest Dermatol. 2014;134(2):526–37. Scholar
  25. 25.
    Wu Y, Huang S, Enhe J, Ma K, Yang S, Sun T, et al. Bone marrow-derived mesenchymal stem cell attenuates skin fibrosis development in mice. Int Wound J. 2014;11(6):701–10. Scholar
  26. 26.
    Huang S, Wu Y, Gao D, Fu X. Paracrine action of mesenchymal stromal cells delivered by microspheres contributes to cutaneous wound healing and prevents scar formation in mice. Cytotherapy. 2015;17(7):922–31. Scholar
  27. 27.
    McFarlin K, Gao X, Liu YB, Dulchavsky DS, Kwon D, Arbab AS, et al. Bone marrow-derived mesenchymal stromal cells accelerate wound healing in the rat. Wound Repair Regen. 2006;14(4):471–478. Scholar
  28. 28.
    Chen L, Xu Y, Zhao J, Zhang Z, Yang R, Xie J, et al. Conditioned medium from hypoxic bone marrow-derived mesenchymal stem cells enhances wound healing in mice. PLoS One. 2014;9(4):e96161. Scholar
  29. 29.
    Li Q, Zhang C, Fu X. Will stem cells bring hope to pathological skin scar treatment? Cytotherapy. 2016;18(8):943–56. Scholar
  30. 30.
    Kwon DS, Gao X, Liu YB, Dulchavsky DS, Danyluk AL, Bansal M, et al. Treatment with bone marrow-derived stromal cells accelerates wound healing in diabetic rats. Int Wound J. 2008;5(3):453–63. Scholar
  31. 31.
    Ding J, Ma Z, Shankowsky HA, Medina A, Tredget EE. Deep dermal fibroblast profibrotic characteristics are enhanced by bone marrow-derived mesenchymal stem cells. Wound Repair Regen. 2013;21(3):448–55. Scholar
  32. 32.
    Fu X, Li H. Mesenchymal stem cells and skin wound repair and regeneration: possibilities and questions. Cell Tissue Res. 2009;335(2):317–21. Scholar
  33. 33.
    Seo SY, Han SI, Bae CS, Cho H, Lim SC. Effect of 15-hydroxyprostaglandin dehydrogenase inhibitor on wound healing. Prostaglandins Leukot Essent Fatty Acids. 2015;97:35–41. Scholar
  34. 34.
    Kieran I, Knock A, Bush J, So K, Metcalfe A, Hobson R, et al. Interleukin-10 reduces scar formation in both animal and human cutaneous wounds: results of two preclinical and phase II randomized control studies. Wound Repair Regen. 2013;21(3):428–36. Scholar
  35. 35.
    Balaji S, Wang X, King A, Le LD, Bhattacharya SS, Moles CM, et al. Interleukin-10-mediated regenerative postnatal tissue repair is dependent on regulation of hyaluronan metabolism via fibroblast-specific STAT3 signaling. FASEB J. 2017;31(3):868–81. Scholar
  36. 36.
    Sandulache VC, Parekh A, Li-Korotky HS, Dohar JE, Hebda PA. Prostaglandin E2 differentially modulates human fetal and adult dermal fibroblast migration and contraction: implication for wound healing. Wound Repair Regen. 2006;14(5):633–643. Scholar
  37. 37.
    Bortolotti F, Ukovich L, Razban V, Martinelli V, Ruozi G, Pelos B, et al. In vivo therapeutic potential of mesenchymal stromal cells depends on the source and the isolation procedure. Stem Cell Rep. 2015;4(3):332–9. Scholar
  38. 38.
    Doi H, Kitajima Y, Luo L, Yan C, Tateishi S, Ono Y, et al. Potency of umbilical cord blood- and Wharton’s jelly-derived mesenchymal stem cells for scarless wound healing. Sci Rep. 2016;6:18844. Scholar
  39. 39.
    Wen ST, Chen W, Chen HL, Lai CW, Yen CC, Lee KH, et al. Amniotic fluid stem cells from EGFP transgenic mice attenuate hyperoxia-induced acute lung injury. PLoS One. 2013;8(9):e75383. Scholar
  40. 40.
    Garcia O, Carraro G, Turcatel G, Hall M, Sedrakyan S, Roche T, et al. Amniotic fluid stem cells inhibit the progression of bleomycin-induced pulmonary fibrosis via CCL2 modulation in bronchoalveolar lavage. PLoS One. 2013;8(8):e71679. Scholar
  41. 41.
    Baulier E, Favreau F, Le Corf A, Jayle C, Schneider F, Goujon JM, et al. Amniotic fluid-derived mesenchymal stem cells prevent fibrosis and preserve renal function in a preclinical porcine model of kidney transplantation. Stem Cells Transl Med. 2014;3(7):809–20. Scholar
  42. 42.
    Sedrakyan S, Da Sacco S, Milanesi A, Shiri L, Petrosyan A, Varimezova R, et al. Injection of amniotic fluid stem cells delays progression of renal fibrosis. J Am Soc Nephrol. 2012;23(4):661–73. Scholar
  43. 43.
    Sun D, Bu L, Liu C, Yin Z, Zhou X, Li X, et al. Therapeutic effects of human amniotic fluid-derived stem cells on renal interstitial fibrosis in a murine model of unilateral ureteral obstruction. PLoS One. 2013;8(5):e65042. Scholar
  44. 44.
    Monteiro Carvalho Mori da Cunha MG, Zia S, Oliveira Arcolino F, Carlon MS, Beckmann DV, Pippi NL, et al. Amniotic fluid derived stem cells with a renal progenitor phenotype inhibit interstitial fibrosis in renal ischemia and reperfusion injury in rats. PLoS One. 2015;10(8):e0136145. Scholar
  45. 45.
    Peng SY, Chou CJ, Cheng PJ, Ko IC, Kao YJ, Chen YH, et al. Therapeutic potential of amniotic-fluid-derived stem cells on liver fibrosis model in mice. Taiwan J Obstet Gynecol. 2014;53(2):151–7. Scholar

Copyright information

© Japan Human Cell Society and Springer Japan KK, part of Springer Nature 2018

Authors and Affiliations

  • Marie Fukutake
    • 1
  • Daigo Ochiai
    • 1
    Email author
  • Hirotaka Masuda
    • 1
  • Yushi Abe
    • 1
  • Yu Sato
    • 1
  • Toshimitsu Otani
    • 1
  • Shigeki Sakai
    • 3
  • Noriko Aramaki-Hattori
    • 3
  • Masayuki Shimoda
    • 2
  • Tadashi Matsumoto
    • 1
  • Kei Miyakoshi
    • 1
  • Yae Kanai
    • 2
  • Kazuo Kishi
    • 3
  • Mamoru Tanaka
    • 1
  1. 1.Department of Obstetrics and GynecologyKeio University School of MedicineTokyoJapan
  2. 2.Department of PathologyKeio University School of MedicineTokyoJapan
  3. 3.Department of Plastic and Reconstructive SurgeryKeio University School of MedicineTokyoJapan

Personalised recommendations